ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 538,29
-0,30%
Dow Jones
39 331,85
0,41%
DAX
18 164,06
-0,86%
Brent Oil
86,40
-0,15%
Bitcoin
61 912,99
-1,49%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Applied Molecular Transport Inc (AMTI)

  7. Applied Molecular Transport Inc (AMTI) Actualités

AMTI

Applied Molecular Transp... (AMTI)

Applied Molecular Transport Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMTI
DateHeureSourceTitreSymboleSociété
09/01/202412h12Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMTIApplied Molecular Transport Inc
03/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h15Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
27/12/202322h15Business WireCyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.NASDAQ:AMTIApplied Molecular Transport Inc
27/12/202321h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
15/12/202322h06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMTIApplied Molecular Transport Inc
21/11/202315h16Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMTIApplied Molecular Transport Inc
09/11/202322h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMTIApplied Molecular Transport Inc
09/11/202322h01GlobeNewswire Inc.Applied Molecular Transport Reports Third Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
27/09/202317h47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AMTIApplied Molecular Transport Inc
21/09/202314h05Business WireCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger AgreementNASDAQ:AMTIApplied Molecular Transport Inc
14/08/202322h01GlobeNewswire Inc.Applied Molecular Transport Reports Second Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
15/06/202323h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
15/06/202322h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
08/06/202322h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMTIApplied Molecular Transport Inc
11/05/202322h05GlobeNewswire Inc.Applied Molecular Transport Reports First Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
28/04/202322h30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMTIApplied Molecular Transport Inc
27/03/202322h01GlobeNewswire Inc.Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic AlternativesNASDAQ:AMTIApplied Molecular Transport Inc
09/03/202322h20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMTIApplied Molecular Transport Inc
09/03/202322h05GlobeNewswire Inc.Applied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:AMTIApplied Molecular Transport Inc
03/03/202314h00GlobeNewswire Inc.Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 CongressNASDAQ:AMTIApplied Molecular Transport Inc
09/02/202322h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMTIApplied Molecular Transport Inc
22/12/202223h30GlobeNewswire Inc.Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202215h10Dow Jones NewsApplied Molecular Transport Gets New FDA Orphan Drug DesignationNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202214h00GlobeNewswire Inc.Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of PouchitisNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202205h25TipRanksSVB Securities Remains a Buy on Applied Molecular Transport (AMTI)NASDAQ:AMTIApplied Molecular Transport Inc
08/11/202214h00GlobeNewswire Inc.Applied Molecular Transport to Present at Upcoming November Investor ConferencesNASDAQ:AMTIApplied Molecular Transport Inc
 Showing the most relevant articles for your search:NASDAQ:AMTI

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
EU
ORA
Orange
EU
PX4
SBF 120
EU
VIV
Vivendi
SPI
SP500
S&P 500
COIN
BTCUSD
Bitcoin
EU
PX1
CAC 40
EU
CAP
Capgemini
EU
MC
Lvmh Moet Hennessy Louis...
COIN
ETHUSD
Ethereum
EU
EN
Bouygues
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés